Butyrylcholinesterase Antikörper (N-Term)

Produktnummer ABIN2781762

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch Butyrylcholinesterase in WB und IHC. Er zeigt eine Reaktivität gegenüber Human, Hund, Maus, Ratte, Rind (Kuh), Pferd, Schaf, Meerschweinchen, Schwein und Kaninchen und wurde in 1 Publikation erwähnt.

Kurzübersicht für Butyrylcholinesterase Antikörper (N-Term) (ABIN2781762)

Target: Butyrylcholinesterase (BCHE)

Reaktivität: Human, Hund, Maus, Ratte, Rind (Kuh), Pferd, Schaf, Meerschweinchen, Schwein, Kaninchen

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Butyrylcholinesterase Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Produktdetails anti-Butyrylcholinesterase Antikörper

Bindungsspezifität: N-Term

Sequenz: SSLHVYDGKF LARVERVIVV SMNYRVGALG FLALPGNPEA PGNMGLFDQQ

Homologie: Cow: 100%, Dog: 100%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 93%, Rat: 100%, Sheep: 100%

Produktmerkmale: This is a rabbit polyclonal antibody against BCHE. It was validated on Western Blot and immunohistochemistry.

Aufreinigung: Protein A purified

Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human BCHE

Anwendungsinformationen

Applikationshinweise: Optimal working dilutions should be determined experimentally by the investigator.

Kommentare:

Antigen size: 602 AA

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freeze-thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Referenzen für anti-Butyrylcholinesterase Antikörper (ABIN2781762)

Mizukami, Akatsu, Abrahamson, Mi, Ikonomovic: "Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease." in: Neuropathology : official journal of the Japanese Society of Neuropathology, Vol. 36, Issue 2, pp. 135-45, (2016) (PubMed).

Details zu Butyrylcholinesterase

Target: Butyrylcholinesterase (BCHE)

Andere Bezeichnung: BCHE

Hintergrund: Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.
Alias Symbols: CHE1, E1
Protein Interaction Partner: COLQ, BCHE,
Protein Size: 602

Molekulargewicht: 68 kDa

Gen-ID: 590

NCBI Accession: NM_000055, NP_000046

UniProt: P06276

Pathways: Peptide Hormone Metabolism